Clinical Trials
131 trialsNCT06191900 2026-04-27
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)
Grit Biotechnology
Phase NA Terminated
NCT06235242 2026-04-27
GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
Grit Biotechnology
Phase NA Terminated
NCT06519669 2026-04-27
Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer
Grit Biotechnology
Phase NA Terminated
NCT05700227 2026-04-21
ARTIA-Bladder
Varian, a Siemens Healthineers Company
Phase NA Terminated
NCT06068400 2026-03-17
Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma
Guangzhou Bio-gene Technology Co., Ltd
Phase NA Terminated
NCT06965309 2026-02-12
Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)
Shenzhen MagicRNA Biotechnology Co., Ltd
Phase NA Terminated
NCT04889989 2026-02-04
Microwave Ablation in Chinese Patients With Lung Tumors
Ethicon, Inc.
Phase NA Terminated
NCT07039461 2026-01-06
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
Lumenis Be Ltd.
Phase NA Terminated
NCT06098248 2025-12-15
cCeLLExvivo
VPIX Medical
Phase NA Terminated
NCT01023412 2025-12-10
IPOD-3
Société des Produits Nestlé (SPN)
Phase NA Terminated
NCT03886181 2025-12-08
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Terminated
NCT05299606 2025-11-24
POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)
Ethicon, Inc.
Phase NA Terminated
NCT05425550 2025-09-22
PRO2
Palleos Healthcare GmbH
Phase NA Terminated
NCT05582018 2025-09-15
PANORAMA
Techsomed Medical Technologies LTD
Phase NA Terminated
NCT05451862 2025-08-26
HOMIE-166
Terumo Europe N.V.
Phase NA Terminated
NCT04773275 2025-08-01
INCITE LS
Galvanize Therapeutics, Inc.
Phase NA Terminated
NCT05010850 2025-07-03
SAFE-2
SafeHeal Inc
Phase NA Terminated
NCT04520906 2025-07-01
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer
Suzhou Hengruihongyuan Medical Technology Co. LTD
Phase NA Terminated
NCT03849820 2025-06-17
OpeRa
Intuitive Surgical
Phase NA Terminated
NCT03740191 2025-05-11
Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer
EBG MedAustron GmbH
Phase NA Terminated
NCT04875871 2025-05-11
PARTICLE-PATHY
EBG MedAustron GmbH
Phase NA Terminated
NCT03127449 2025-04-03
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Allist Pharmaceuticals, Inc.
Phase NA Terminated
NCT04858230 2025-03-07
LymphoPilot Test for Limb Lymphedema
Lymphatica Medtech SA
Phase NA Terminated
NCT00051532 2025-02-25
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
LEO Pharma
Phase NA Terminated
NCT03717142 2025-01-15
Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
Lumicell, Inc.
Phase NA Terminated
NCT04436120 2024-12-03
TRANSLATE
Pfizer
Phase NA Terminated
NCT05188586 2024-09-19
NODMED
ClearNote Health
Phase NA Terminated
NCT05553392 2024-09-04
StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
Stratpharma AG
Phase NA Terminated
NCT04815291 2024-05-21
Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc )
Merit Medical Systems, Inc.
Phase NA Terminated
NCT05732233 2024-05-13
RITUAL
Satisfai Health, Inc.
Phase NA Terminated
NCT03400748 2024-04-03
ANET Electrosurgery Applicator Pilot Evaluation Study
Olympus Corporation of the Americas
Phase NA Terminated
NCT05133128 2024-02-22
IMMUNOPBMC
Servier
Phase NA Terminated
NCT03970967 2024-01-18
Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases
Alpha Tau Medical LTD.
Phase NA Terminated
NCT03753789 2024-01-05
Ablation Confirmation Study
Ethicon, Inc.
Phase NA Terminated
NCT05910697 2023-11-15
Clinical Utility of MyProstateScore 2.0 P2
Qure Healthcare, LLC
Phase NA Terminated
NCT04249115 2023-10-30
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study
Pulse Biosciences, Inc.
Phase NA Terminated
NCT06069453 2023-10-05
Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.
Fidia Farmaceutici s.p.a.
Phase NA Terminated
NCT05351866 2023-08-04
Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management
Limbix Health, Inc.
Phase NA Terminated
NCT05010759 2023-08-01
Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer
MagForce USA
Phase NA Terminated
NCT04314700 2023-05-26
Intraoperative Use of an Optical Coherence Tomography (OCT) Imaging System to Guide Additional Margin Cavity Shaves in Breast Conserving Surgery (BCS)
Perimeter Medical Imaging
Phase NA Terminated
NCT05199961 2023-05-12
Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel
Pack Health
Phase NA Terminated
NCT02968784 2023-05-09
Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer
InSightec
Phase NA Terminated
NCT05361356 2023-04-07
Spectral CT Clinical Trial
Philips (China) Investment CO., LTD
Phase NA Terminated
NCT03249727 2023-01-31
ANKA-HR
ATGen Canada Inc
Phase NA Terminated
NCT04073823 2023-01-18
A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients
Tactile Medical
Phase NA Terminated
NCT04453046 2022-12-20
Hemopurifier Plus Pembrolizumab in Head and Neck Cancer
Aethlon Medical Inc.
Phase NA Terminated
NCT04857008 2022-10-20
BNT001 Digital Therapeutic Feasibility Pilot Study
Blue Note Therapeutics
Phase NA Terminated
NCT04862195 2022-09-13
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment
Blue Note Therapeutics
Phase NA Terminated
NCT02872298 2022-04-12
RELIEF-1
Nuvaira, Inc.
Phase NA Terminated
NCT04555135 2022-04-01
ColonCADe
EndoVigilant Inc
Phase NA Terminated